ID   KHM-1A
AC   CVCL_9546
SY   KHM1A
DR   Wikidata; Q54899887
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=2458153;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgA lambda.
CC   Doubling time: ~5 days (PubMed=2458153).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2972 ! KHM-1B
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York (2000).
//
RX   PubMed=2458153; DOI=10.1182/blood.V72.3.978.978;
RA   Matsuzaki H., Hata H., Takeya M., Takatsuki K.;
RT   "Establishment and characterization of an amylase-producing human
RT   myeloma cell line.";
RL   Blood 72:978-982(1988).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//